Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
David Amsellem is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/12/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/03/2025 | CORT | Buy Now | Corcept Therapeutics | $69.09 | 89.61% | David Amsellem69% | $128 → $131 | Maintains | Overweight | Get Alert |
| 03/21/2025 | AMPH | Buy Now | Amphastar Pharma | $24.16 | 32.45% | David Amsellem69% | $36 → $32 | Maintains | Neutral | Get Alert |
| 03/21/2025 | OPTN | Buy Now | OptiNose | $9.03 | -0.33% | David Amsellem69% | $15 → $9 | Downgrade | Overweight → Neutral | Get Alert |
| 03/07/2025 | XERS | Buy Now | Xeris Biopharma Holdings | $4.01 | -0.27% | David Amsellem69% | $3 → $4 | Reiterates | Neutral → Neutral | Get Alert |
| 03/06/2025 | INDV | Buy Now | Indivior | $9.11 | 42.7% | David Amsellem69% | $16 → $13 | Maintains | Overweight | Get Alert |
| 03/05/2025 | VTRS | Buy Now | Viatris | $7.46 | 33.99% | David Amsellem69% | $14 → $10 | Reiterates | Neutral → Neutral | Get Alert |
| 02/27/2025 | CORT | Buy Now | Corcept Therapeutics | $69.09 | 12.9% | David Amsellem69% | $67 → $78 | Maintains | Overweight | Get Alert |
| 02/26/2025 | JAZZ | Buy Now | Jazz Pharmaceuticals | $99.75 | 76.44% | David Amsellem69% | $163 → $176 | Reiterates | Overweight → Overweight | Get Alert |
| 02/10/2025 | AMGN | Buy Now | Amgen | $286.64 | 14.78% | David Amsellem69% | $310 → $329 | Maintains | Overweight | Get Alert |
| 02/04/2025 | AMPH | Buy Now | Amphastar Pharma | $24.16 | 49.01% | David Amsellem69% | $66 → $36 | Downgrade | Overweight → Neutral | Get Alert |
| 02/04/2025 | COLL | Buy Now | Collegium Pharmaceutical | $26.30 | 36.88% | David Amsellem69% | $37 → $36 | Maintains | Neutral | Get Alert |
| 01/17/2025 | TEVA | Buy Now | Teva Pharmaceutical Indus | $13.36 | 124.55% | David Amsellem69% | $23 → $30 | Maintains | Overweight | Get Alert |
| 01/14/2025 | ITCI | Buy Now | Intra-Cellular Therapies | $131.92 | 0.06% | David Amsellem69% | $107 → $132 | Downgrade | Overweight → Neutral | Get Alert |
| 01/10/2025 | AVDL | Buy Now | Avadel Pharmaceuticals | $7.68 | 69.27% | David Amsellem69% | $24 → $13 | Maintains | Overweight | Get Alert |
| 01/02/2025 | SAGE | Buy Now | Sage Therapeutics | $7.16 | 25.7% | David Amsellem69% | $26 → $9 | Maintains | Overweight | Get Alert |
| 01/02/2025 | AMGN | Buy Now | Amgen | $286.64 | 8.15% | David Amsellem69% | $344 → $310 | Maintains | Overweight | Get Alert |
| 12/23/2024 | NBIX | Buy Now | Neurocrine Biosciences | $90.87 | 76.08% | David Amsellem69% | $160 → $160 | Reiterates | Overweight → Overweight | Get Alert |
| 12/12/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $99.75 | 63.41% | David Amsellem69% | $163 → $163 | Reiterates | Overweight → Overweight | Get Alert |
| 12/06/2024 | VTRS | Buy Now | Viatris | $7.46 | 87.58% | David Amsellem69% | $13 → $14 | Reiterates | Neutral → Neutral | Get Alert |
| 11/21/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $99.75 | 63.41% | David Amsellem69% | $166 → $163 | Reiterates | Overweight → Overweight | Get Alert |
| 11/13/2024 | OPTN | Buy Now | OptiNose | $9.03 | -88.93% | David Amsellem69% | $45 → $15 | Maintains | Overweight | Get Alert |
| 11/11/2024 | AMRX | Buy Now | Amneal Pharmaceuticals | $6.98 | 57.59% | David Amsellem69% | $9 → $11 | Maintains | Overweight | Get Alert |
| 11/11/2024 | XERS | Buy Now | Xeris Biopharma Holdings | $4.01 | -25.2% | David Amsellem69% | $3 → $3 | Downgrade | Overweight → Neutral | Get Alert |
| 10/25/2024 | ALKS | Buy Now | Alkermes | $27.00 | 37.04% | David Amsellem69% | $38 → $37 | Reiterates | Overweight → Overweight | Get Alert |
| 10/25/2024 | INDV | Buy Now | Indivior | $9.11 | 75.63% | David Amsellem69% | $15 → $16 | Reiterates | Overweight → Overweight | Get Alert |
| 10/11/2024 | COLL | Buy Now | Collegium Pharmaceutical | $26.30 | 40.68% | David Amsellem69% | $37 → $37 | Reiterates | Neutral → Neutral | Get Alert |
| 10/11/2024 | INDV | Buy Now | Indivior | $9.11 | 64.65% | David Amsellem69% | $22 → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 10/11/2024 | ANIP | Buy Now | ANI Pharmaceuticals | $68.12 | -0.18% | David Amsellem69% | → $68 | Initiates | → Overweight | Get Alert |
| 09/18/2024 | CORT | Buy Now | Corcept Therapeutics | $69.09 | -3.03% | David Amsellem69% | $38 → $67 | Maintains | Overweight | Get Alert |
| 09/13/2024 | INDV | Buy Now | Indivior | $9.11 | 141.49% | David Amsellem69% | $22 → $22 | Reiterates | Overweight → Overweight | Get Alert |
| 09/11/2024 | SUPN | Buy Now | Supernus Pharmaceuticals | $31.67 | 13.67% | David Amsellem69% | $41 → $36 | Downgrade | Overweight → Neutral | Get Alert |
| 08/29/2024 | NBIX | Buy Now | Neurocrine Biosciences | $90.87 | 74.98% | David Amsellem69% | $131 → $159 | Upgrade | Neutral → Overweight | Get Alert |
| 08/09/2024 | COLL | Buy Now | Collegium Pharmaceutical | $26.30 | 40.68% | David Amsellem69% | $39 → $37 | Reiterates | Neutral → Neutral | Get Alert |
| 08/09/2024 | RVNC | Buy Now | Revance Therapeutics | — | — | David Amsellem69% | $11 → $6 | Maintains | Overweight | Get Alert |
| 08/08/2024 | AMPH | Buy Now | Amphastar Pharma | $24.16 | 173.18% | David Amsellem69% | $71 → $66 | Maintains | Overweight | Get Alert |
| 08/02/2024 | BHC | Buy Now | Bausch Health Companies | $4.53 | -33.77% | David Amsellem69% | $9 → $3 | Downgrade | Neutral → Underweight | Get Alert |
| 08/01/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $99.75 | 66.42% | David Amsellem69% | $188 → $166 | Maintains | Overweight | Get Alert |
| 07/30/2024 | CORT | Buy Now | Corcept Therapeutics | $69.09 | -45% | David Amsellem69% | $35 → $38 | Maintains | Overweight | Get Alert |
| 07/23/2024 | INDV | Buy Now | Indivior | $9.11 | 141.49% | David Amsellem69% | → $22 | Initiates | → Overweight | Get Alert |
| 07/03/2024 | PCRX | Buy Now | Pacira BioSciences | $24.56 | 71.01% | David Amsellem69% | $42 → $42 | Maintains | Overweight | Get Alert |
| 07/01/2024 | CORT | Buy Now | Corcept Therapeutics | $69.09 | -49.34% | David Amsellem69% | $35 → $35 | Reiterates | Overweight → Overweight | Get Alert |
| 06/27/2024 | AMPH | Buy Now | Amphastar Pharma | $24.16 | 193.87% | David Amsellem69% | $71 → $71 | Reiterates | Overweight → Overweight | Get Alert |
| 05/13/2024 | TEVA | Buy Now | Teva Pharmaceutical Indus | $13.36 | 49.7% | David Amsellem69% | $19 → $20 | Reiterates | Overweight → Overweight | Get Alert |
| 05/10/2024 | XERS | Buy Now | Xeris Biopharma Holdings | $4.01 | -25.2% | David Amsellem69% | $4 → $3 | Reiterates | Overweight → Overweight | Get Alert |
| 05/10/2024 | RVNC | Buy Now | Revance Therapeutics | — | — | David Amsellem69% | $20 → $11 | Reiterates | Overweight → Overweight | Get Alert |
| 05/10/2024 | COLL | Buy Now | Collegium Pharmaceutical | $26.30 | 48.29% | David Amsellem69% | $39 → $39 | Downgrade | Overweight → Neutral | Get Alert |
| 04/29/2024 | OGN | Buy Now | Organon | $11.20 | 114.29% | David Amsellem69% | $22 → $24 | Maintains | Overweight | Get Alert |
| 04/11/2024 | AQST | Buy Now | Aquestive Therapeutics | $2.58 | 287.6% | David Amsellem69% | → $10 | Initiates | → Overweight | Get Alert |
| 04/01/2024 | ALKS | Buy Now | Alkermes | $27.00 | 44.44% | David Amsellem69% | $39 → $39 | Reiterates | Overweight → Overweight | Get Alert |
| 03/28/2024 | VTRS | Buy Now | Viatris | $7.46 | 74.19% | David Amsellem69% | $11 → $13 | Reiterates | Neutral → Neutral | Get Alert |
| 03/21/2024 | AMRX | Buy Now | Amneal Pharmaceuticals | $6.98 | 14.61% | David Amsellem69% | $6 → $8 | Maintains | Overweight | Get Alert |
| 03/20/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $99.75 | 88.47% | David Amsellem69% | $171 → $188 | Reiterates | Overweight → Overweight | Get Alert |
| 03/05/2024 | AVDL | Buy Now | Avadel Pharmaceuticals | $7.68 | 199.48% | David Amsellem69% | $18 → $23 | Maintains | Overweight | Get Alert |
| 02/29/2024 | RVNC | Buy Now | Revance Therapeutics | — | — | David Amsellem69% | $42 → $20 | Maintains | Overweight | Get Alert |
| 02/28/2024 | SUPN | Buy Now | Supernus Pharmaceuticals | $31.67 | 29.46% | David Amsellem69% | $45 → $41 | Maintains | Overweight | Get Alert |
| 02/23/2024 | COLL | Buy Now | Collegium Pharmaceutical | $26.30 | 48.29% | David Amsellem69% | $37 → $39 | Reiterates | Overweight → Overweight | Get Alert |
| 02/16/2024 | ALKS | Buy Now | Alkermes | $27.00 | 44.44% | David Amsellem69% | $35 → $39 | Maintains | Overweight | Get Alert |
| 02/16/2024 | IRWD | Buy Now | Ironwood Pharmaceuticals | $0.98 | 2050.32% | David Amsellem69% | $20 → $21 | Maintains | Overweight | Get Alert |
| 02/12/2024 | TEVA | Buy Now | Teva Pharmaceutical Indus | $13.36 | 42.22% | David Amsellem69% | $12 → $19 | Upgrade | Neutral → Overweight | Get Alert |
| 01/16/2024 | AXSM | Buy Now | Axsome Therapeutics | $97.90 | 15.42% | David Amsellem69% | $90 → $113 | Maintains | Overweight | Get Alert |
| 01/03/2024 | TEVA | Buy Now | Teva Pharmaceutical Indus | $13.36 | -10.18% | David Amsellem69% | $8 → $12 | Upgrade | Underweight → Neutral | Get Alert |
| 12/07/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | David Amsellem69% | $33 → $45 | Downgrade | Overweight → Neutral | Get Alert |
| 11/22/2023 | VTRS | Buy Now | Viatris | $7.46 | 47.39% | David Amsellem69% | $10 → $11 | Maintains | Neutral | Get Alert |
| 11/22/2023 | OGN | Buy Now | Organon | $11.20 | 96.43% | David Amsellem69% | $32 → $22 | Maintains | Overweight | Get Alert |
| 11/14/2023 | CARA | Buy Now | Cara Therapeutics | $4.71 | -78.77% | David Amsellem69% | $144 → $12 | Downgrade | Overweight → Neutral | Get Alert |
| 11/10/2023 | XERS | Buy Now | Xeris Biopharma Holdings | $4.01 | -0.27% | David Amsellem69% | $5 → $4 | Maintains | Overweight | Get Alert |
| 11/09/2023 | SUPN | Buy Now | Supernus Pharmaceuticals | $31.67 | 35.78% | David Amsellem69% | $42 → $43 | Maintains | Overweight | Get Alert |
| 11/09/2023 | RVNC | Buy Now | Revance Therapeutics | — | — | David Amsellem69% | $44 → $42 | Maintains | Overweight | Get Alert |
| 11/03/2023 | PCRX | Buy Now | Pacira BioSciences | $24.56 | 71.01% | David Amsellem69% | $50 → $42 | Maintains | Overweight | Get Alert |
| 11/01/2023 | NBIX | Buy Now | Neurocrine Biosciences | $90.87 | 10.05% | David Amsellem69% | $95 → $100 | Maintains | Neutral | Get Alert |
| 10/27/2023 | ALKS | Buy Now | Alkermes | $27.00 | 29.63% | David Amsellem69% | $37 → $35 | Maintains | Overweight | Get Alert |
| 10/25/2023 | SUPN | Buy Now | Supernus Pharmaceuticals | $31.67 | 32.62% | David Amsellem69% | $43 → $42 | Maintains | Overweight | Get Alert |
| 10/25/2023 | OGN | Buy Now | Organon | $11.20 | 185.71% | David Amsellem69% | $33 → $32 | Maintains | Overweight | Get Alert |
| 10/16/2023 | HRMY | Buy Now | Harmony Biosciences | $29.17 | 43.98% | David Amsellem69% | $72 → $42 | Maintains | Overweight | Get Alert |
| 09/28/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | David Amsellem69% | → $33 | Initiates | → Overweight | Get Alert |
| 09/20/2023 | RVNC | Buy Now | Revance Therapeutics | — | — | David Amsellem69% | $50 → $44 | Maintains | Overweight | Get Alert |
| 08/11/2023 | OPTN | Buy Now | OptiNose | $9.03 | -66.78% | David Amsellem69% | $60 → $45 | Maintains | Overweight | Get Alert |
| 08/10/2023 | AVDL | Buy Now | Avadel Pharmaceuticals | $7.68 | 134.38% | David Amsellem69% | $13 → $18 | Maintains | Overweight | Get Alert |
| 08/09/2023 | EGRX | Buy Now | Eagle Pharmaceuticals | $2.30 | 639.13% | David Amsellem69% | $26 → $17 | Downgrade | Neutral → Underweight | Get Alert |
| 08/08/2023 | CARA | Buy Now | Cara Therapeutics | $4.71 | 154.78% | David Amsellem69% | $156 → $144 | Maintains | Overweight | Get Alert |
| 08/08/2023 | AXSM | Buy Now | Axsome Therapeutics | $97.90 | -8.07% | David Amsellem69% | $70 → $90 | Upgrade | Neutral → Overweight | Get Alert |
| 08/07/2023 | AMRX | Buy Now | Amneal Pharmaceuticals | $6.98 | -28.37% | David Amsellem69% | $3 → $5 | Maintains | Overweight | Get Alert |
| 08/03/2023 | CORT | Buy Now | Corcept Therapeutics | $69.09 | -55.13% | David Amsellem69% | $27 → $31 | Maintains | Overweight | Get Alert |
| 08/03/2023 | PCRX | Buy Now | Pacira BioSciences | $24.56 | 103.58% | David Amsellem69% | $60 → $50 | Maintains | Overweight | Get Alert |
| 06/07/2023 | ALKS | Buy Now | Alkermes | $27.00 | 37.04% | David Amsellem69% | $35 → $37 | Maintains | Overweight | Get Alert |
| 05/23/2023 | IRWD | Buy Now | Ironwood Pharmaceuticals | $0.98 | 1845.53% | David Amsellem69% | $16 → $19 | Maintains | Overweight | Get Alert |
| 05/15/2023 | PCRX | Buy Now | Pacira BioSciences | $24.56 | 144.3% | David Amsellem69% | → $60 | Maintains | Overweight | Get Alert |
| 05/10/2023 | SUPN | Buy Now | Supernus Pharmaceuticals | $31.67 | 45.25% | David Amsellem69% | $45 → $46 | Maintains | Overweight | Get Alert |
| 05/08/2023 | AMRX | Buy Now | Amneal Pharmaceuticals | $6.98 | -57.02% | David Amsellem69% | $5 → $3 | Maintains | Overweight | Get Alert |
| 04/25/2023 | PCRX | Buy Now | Pacira BioSciences | $24.56 | 152.44% | David Amsellem69% | → $65 | Maintains | Overweight | Get Alert |
| 04/04/2023 | CORT | Buy Now | Corcept Therapeutics | $69.09 | -60.92% | David Amsellem69% | → $27 | Initiates | → Overweight | Get Alert |
| 03/07/2023 | CARA | Buy Now | Cara Therapeutics | $4.71 | 176.01% | David Amsellem69% | $300 → $156 | Maintains | Overweight | Get Alert |
| 02/07/2023 | NBIX | Buy Now | Neurocrine Biosciences | $90.87 | 4.54% | David Amsellem69% | $103 → $95 | Maintains | Neutral | Get Alert |
| 01/31/2023 | RVNC | Buy Now | Revance Therapeutics | — | — | David Amsellem69% | $29 → $40 | Maintains | Overweight | Get Alert |
| 01/23/2023 | SUPN | Buy Now | Supernus Pharmaceuticals | $31.67 | 48.41% | David Amsellem69% | $40 → $47 | Maintains | Overweight | Get Alert |
| 01/05/2023 | AXSM | Buy Now | Axsome Therapeutics | $97.90 | -23.39% | David Amsellem69% | → $75 | Initiates | → Neutral | Get Alert |
| 01/05/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | David Amsellem69% | → $285 | Initiates | → Overweight | Get Alert |
| 01/04/2023 | HRMY | Buy Now | Harmony Biosciences | $29.17 | 139.97% | David Amsellem69% | $62 → $70 | Maintains | Overweight | Get Alert |
| 12/07/2022 | HZNP | Buy Now | Horizon Therapeutics | — | — | David Amsellem69% | $90 → $110 | Maintains | Overweight | Get Alert |
| 11/23/2022 | TEVA | Buy Now | Teva Pharmaceutical Indus | $13.36 | -47.6% | David Amsellem69% | $8 → $7 | Maintains | Underweight | Get Alert |
| 11/08/2022 | VTRS | Buy Now | Viatris | $7.46 | 33.99% | David Amsellem69% | → $10 | Upgrade | Underweight → Neutral | Get Alert |
| 11/03/2022 | ALKS | Buy Now | Alkermes | $27.00 | 11.11% | David Amsellem69% | $26 → $30 | Upgrade | Neutral → Overweight | Get Alert |
| 11/02/2022 | NBIX | Buy Now | Neurocrine Biosciences | $90.87 | 13.35% | David Amsellem69% | $91 → $103 | Maintains | Neutral | Get Alert |
| 10/25/2022 | HZNP | Buy Now | Horizon Therapeutics | — | — | David Amsellem69% | $90 → $88 | Maintains | Overweight | Get Alert |
| 10/25/2022 | AMPH | Buy Now | Amphastar Pharma | $24.16 | 65.56% | David Amsellem69% | $43 → $40 | Maintains | Overweight | Get Alert |
| 09/09/2022 | BHC | Buy Now | Bausch Health Companies | $4.53 | 32.45% | David Amsellem69% | $7 → $6 | Maintains | Neutral | Get Alert |
| 09/06/2022 | OGN | Buy Now | Organon | $11.20 | 203.57% | David Amsellem69% | $37 → $34 | Upgrade | Neutral → Overweight | Get Alert |
| 08/31/2022 | SUPN | Buy Now | Supernus Pharmaceuticals | $31.67 | 19.99% | David Amsellem69% | $33 → $38 | Maintains | Overweight | Get Alert |
| 08/16/2022 | ALKS | Buy Now | Alkermes | $27.00 | -3.7% | David Amsellem69% | → $26 | Initiates | → Neutral | Get Alert |
| 08/04/2022 | PCRX | Buy Now | Pacira BioSciences | $24.56 | 209.45% | David Amsellem69% | $80 → $76 | Maintains | Overweight | Get Alert |
| 07/21/2022 | PCRX | Buy Now | Pacira BioSciences | $24.56 | 225.73% | David Amsellem69% | $84 → $80 | Maintains | Overweight | Get Alert |
| 05/25/2022 | EVFM | Buy Now | Evofem Biosciences | $0.01 | 20952.63% | David Amsellem69% | $3750 → $250 | Maintains | Overweight | Get Alert |
| 05/10/2022 | VTRS | Buy Now | Viatris | $7.46 | 33.99% | David Amsellem69% | → $10 | Downgrade | Neutral → Underweight | Get Alert |
| 05/05/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $99.75 | 93.48% | David Amsellem69% | $197 → $193 | Maintains | Overweight | Get Alert |
| 05/04/2022 | TEVA | Buy Now | Teva Pharmaceutical Indus | $13.36 | -47.6% | David Amsellem69% | $11 → $7 | Downgrade | Neutral → Underweight | Get Alert |
| 04/22/2022 | IRWD | Buy Now | Ironwood Pharmaceuticals | $0.98 | 1538.34% | David Amsellem69% | → $16 | Initiates | → Overweight | Get Alert |
| 04/14/2022 | ATRS | Buy Now | Antares Pharma | — | — | David Amsellem69% | $6 → $5.6 | Downgrade | Overweight → Neutral | Get Alert |
| 03/16/2022 | VTRS | Buy Now | Viatris | $7.46 | 33.99% | David Amsellem69% | $17 → $10 | Maintains | Neutral | Get Alert |
| 03/11/2022 | AMPH | Buy Now | Amphastar Pharma | $24.16 | 44.87% | David Amsellem69% | $28 → $35 | Maintains | Overweight | Get Alert |
| 03/03/2022 | NBIX | Buy Now | Neurocrine Biosciences | $90.87 | 3.44% | David Amsellem69% | $114 → $94 | Downgrade | Overweight → Neutral | Get Alert |
| 03/02/2022 | ENDP | Buy Now | Endo International | — | — | David Amsellem69% | $5 → $3 | Maintains | Neutral | Get Alert |
| 03/02/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $99.75 | 97.49% | David Amsellem69% | $209 → $197 | Maintains | Overweight | Get Alert |
| 02/22/2022 | COLL | Buy Now | Collegium Pharmaceutical | $26.30 | 59.7% | David Amsellem69% | $36 → $42 | Maintains | Overweight | Get Alert |
| 02/15/2022 | BDSI | Buy Now | BioDelivery Sciences Intl | — | — | David Amsellem69% | $5 → $5.6 | Downgrade | Overweight → Neutral | Get Alert |
| 01/07/2022 | AMPH | Buy Now | Amphastar Pharma | $24.16 | 15.89% | David Amsellem69% | $21 → $28 | Upgrade | Neutral → Overweight | Get Alert |
| 10/12/2021 | ADMS | Buy Now | Adamas Pharmaceuticals | — | — | David Amsellem69% | $7 → $8 | Downgrade | Overweight → Neutral | Get Alert |
| 10/07/2021 | OGN | Buy Now | Organon | $11.20 | 212.5% | David Amsellem69% | → $35 | Initiates | → Neutral | Get Alert |
| 02/24/2021 | JAZZ | Buy Now | Jazz Pharmaceuticals | $99.75 | 105.51% | David Amsellem69% | $175 → $205 | Maintains | Overweight | Get Alert |
| 01/22/2021 | BHC | Buy Now | Bausch Health Companies | $4.53 | 740.18% | David Amsellem69% | → $38.06 | Downgrade | Overweight → Neutral | Get Alert |
| 11/05/2020 | BHC | Buy Now | Bausch Health Companies | $4.53 | 451.88% | David Amsellem69% | $26 → $25 | Maintains | Overweight | Get Alert |
| 10/09/2020 | ENDP | Buy Now | Endo International | — | — | David Amsellem69% | $5 → $6 | Maintains | Overweight | Get Alert |
| 09/14/2020 | HRMY | Buy Now | Harmony Biosciences | $29.17 | 109.12% | David Amsellem69% | → $61 | Initiates | → Overweight | Get Alert |
| 08/19/2020 | BHC | Buy Now | Bausch Health Companies | $4.53 | 473.95% | David Amsellem69% | $32 → $26 | Maintains | Overweight | Get Alert |
| 06/16/2020 | SUPN | Buy Now | Supernus Pharmaceuticals | $31.67 | -2.12% | David Amsellem69% | $25 → $31 | Upgrade | Neutral → Overweight | Get Alert |
| 06/08/2020 | EVFM | Buy Now | Evofem Biosciences | $0.01 | 115689.47% | David Amsellem69% | → $165 | Initiates | → Overweight | Get Alert |
| 05/04/2020 | AVDL | Buy Now | Avadel Pharmaceuticals | $7.68 | 134.38% | David Amsellem69% | $14 → $18 | Maintains | Overweight | Get Alert |
| 04/15/2020 | TEVA | Buy Now | Teva Pharmaceutical Indus | $13.36 | -40.12% | David Amsellem69% | $10 → $8 | Maintains | Neutral | Get Alert |
| 04/15/2020 | ENDP | Buy Now | Endo International | — | — | David Amsellem69% | $7 → $6 | Maintains | Overweight | Get Alert |
| 04/15/2020 | MYL | Buy Now | Mylan | — | — | David Amsellem69% | $23 → $17 | Maintains | Neutral | Get Alert |
| 04/14/2020 | HZNP | Buy Now | Horizon Therapeutics | — | — | David Amsellem69% | $46 → $44 | Maintains | Overweight | Get Alert |
| 02/26/2020 | AVDL | Buy Now | Avadel Pharmaceuticals | $7.68 | 82.29% | David Amsellem69% | → $14 | Initiates | → Overweight | Get Alert |
| 02/25/2020 | RVNC | Buy Now | Revance Therapeutics | — | — | David Amsellem69% | $37 → $40 | Reiterates | → Overweight | Get Alert |
| 02/18/2020 | RVNC | Buy Now | Revance Therapeutics | — | — | David Amsellem69% | $38 → $37 | Maintains | Overweight | Get Alert |
| 02/18/2020 | XERS | Buy Now | Xeris Biopharma Holdings | $4.01 | 199.19% | David Amsellem69% | → $12 | Initiates | → Overweight | Get Alert |
| 02/12/2020 | COLL | Buy Now | Collegium Pharmaceutical | $26.30 | 33.08% | David Amsellem69% | $27 → $35 | Maintains | Overweight | Get Alert |
| 01/03/2020 | ENDP | Buy Now | Endo International | — | — | David Amsellem69% | $5 → $7 | Upgrade | Neutral → Overweight | Get Alert |
| 12/30/2019 | BHC | Buy Now | Bausch Health Companies | $4.53 | 760.93% | David Amsellem69% | $30 → $39 | Maintains | Overweight | Get Alert |
| 11/08/2019 | TEVA | Buy Now | Teva Pharmaceutical Indus | $13.36 | -47.6% | David Amsellem69% | $6 → $7 | Maintains | Neutral | Get Alert |
| 08/21/2019 | JAZZ | Buy Now | Jazz Pharmaceuticals | $99.75 | 42.36% | David Amsellem69% | $205 → $142 | Downgrade | Overweight → Neutral | Get Alert |
| 07/30/2019 | NBIX | Buy Now | Neurocrine Biosciences | $90.87 | 22.15% | David Amsellem69% | $103 → $111 | Maintains | Overweight | Get Alert |
| 01/23/2019 | TEVA | Buy Now | Teva Pharmaceutical Indus | $13.36 | 19.76% | David Amsellem69% | $15 → $16 | Upgrade | Underweight → Neutral | Get Alert |
| 01/02/2019 | BHC | Buy Now | Bausch Health Companies | $4.53 | — | David Amsellem69% | — | Upgrade | Neutral → Overweight | Get Alert |
| 10/31/2018 | EGRX | Buy Now | Eagle Pharmaceuticals | $2.30 | 2247.83% | David Amsellem69% | $82 → $54 | Downgrade | Overweight → Neutral | Get Alert |
| 10/17/2018 | AKRX | Buy Now | Akorn | — | — | David Amsellem69% | → $9 | Upgrade | Neutral → Overweight | Get Alert |
| 09/13/2018 | BHC | Buy Now | Bausch Health Companies | $4.53 | 319.43% | David Amsellem69% | $16 → $19 | Upgrade | Underweight → Neutral | Get Alert |
| 03/09/2018 | INSY | Buy Now | Insys Therapeutics | — | — | David Amsellem69% | — | Downgrade | Neutral → Underweight | Get Alert |
| 02/09/2018 | TEVA | Buy Now | Teva Pharmaceutical Indus | $13.36 | — | David Amsellem69% | — | Downgrade | Neutral → Underweight | Get Alert |
| 07/18/2017 | IPXL | Buy Now | Impax Laboratories | — | — | David Amsellem69% | — | Upgrade | Underweight → Neutral | Get Alert |
| 07/17/2017 | SUPN | Buy Now | Supernus Pharmaceuticals | $31.67 | — | David Amsellem69% | — | Downgrade | Overweight → Neutral | Get Alert |
| 06/01/2017 | SUPN | Buy Now | Supernus Pharmaceuticals | $31.67 | 38.93% | David Amsellem69% | $30 → $44 | Upgrade | Neutral → Overweight | Get Alert |
| 05/10/2017 | INSY | Buy Now | Insys Therapeutics | — | — | David Amsellem69% | — | Downgrade | Overweight → Neutral | Get Alert |
| 05/10/2017 | DEPO | Buy Now | Depomed | — | — | David Amsellem69% | — | Upgrade | Underweight → Neutral | Get Alert |
| 04/25/2017 | AKRX | Buy Now | Akorn | — | — | David Amsellem69% | — | Downgrade | Overweight → Neutral | Get Alert |
| 12/19/2016 | REPH | Buy Now | Recro Pharma | — | — | David Amsellem69% | → $12 | Initiates | → Overweight | Get Alert |
| 12/12/2016 | DEPO | Buy Now | Depomed | — | — | David Amsellem69% | — | Downgrade | Neutral → Underweight | Get Alert |
| 09/15/2016 | AKRX | Buy Now | Akorn | — | — | David Amsellem69% | $33 → $34 | Upgrade | Neutral → Overweight | Get Alert |
| 07/27/2016 | DEPO | Buy Now | Depomed | — | — | David Amsellem69% | — | Downgrade | Overweight → Neutral | Get Alert |
| 07/18/2016 | SUPN | Buy Now | Supernus Pharmaceuticals | $31.67 | — | David Amsellem69% | — | Downgrade | Overweight → Neutral | Get Alert |
| 05/06/2016 | ENDP | Buy Now | Endo International | — | — | David Amsellem69% | — | Downgrade | Overweight → Neutral | Get Alert |
| 02/08/2016 | BDSI | Buy Now | BioDelivery Sciences Intl | — | — | David Amsellem69% | → $6 | Assumes | → Overweight | Get Alert |
| 02/08/2016 | DEPO | Buy Now | DepoMed | — | — | David Amsellem69% | → $23 | Assumes | → Overweight | Get Alert |
| 11/10/2015 | JAZZ | Buy Now | Jazz Pharmaceuticals | $99.75 | 86.47% | David Amsellem69% | $208 → $186 | Maintains | Overweight | Get Alert |
| 08/12/2015 | EGRX | Buy Now | Eagle Pharmaceuticals | $2.30 | 5117.39% | David Amsellem69% | $119 → $120 | Maintains | Overweight | Get Alert |
| 07/21/2015 | HZNP | Buy Now | Horizon Therapeutics | — | — | David Amsellem69% | $38 → $48 | Maintains | Overweight | Get Alert |
| 06/18/2015 | SUPN | Buy Now | Supernus Pharmaceuticals | $31.67 | -36.85% | David Amsellem69% | $16 → $20 | Maintains | Overweight | Get Alert |
| 06/17/2015 | NBIX | Buy Now | Neurocrine Biosciences | $90.87 | -4.26% | David Amsellem69% | $63 → $87 | Maintains | Overweight | Get Alert |
| 05/18/2015 | ATRS | Buy Now | Antares Pharma | — | — | David Amsellem69% | → $3.5 | Initiates | → Overweight | Get Alert |
| 04/27/2015 | AKRX | Buy Now | Akorn | — | — | David Amsellem69% | — | Downgrade | Overweight → Neutral | Get Alert |
| 04/22/2015 | DEPO | Buy Now | DepoMed | — | — | David Amsellem69% | → $37 | Initiates | → Overweight | Get Alert |
| 03/31/2015 | HZNP | Buy Now | Horizon Therapeutics | — | — | David Amsellem69% | $21 → $31 | Upgrade | Neutral → Overweight | Get Alert |
| 03/11/2015 | IPXL | Buy Now | Impax Laboratories | — | — | David Amsellem69% | — | Upgrade | Neutral → Overweight | Get Alert |
| 11/05/2014 | IPXL | Buy Now | Impax Laboratories, Inc. | — | — | David Amsellem69% | — | Downgrade | Overweight → Neutral | Get Alert |
| 10/29/2014 | INSY | Buy Now | Insys Therapeutics | — | — | David Amsellem69% | → $25.5 | Initiates | → Overweight | Get Alert |
| 07/29/2014 | HZNP | Buy Now | Horizon Therapeutics | — | — | David Amsellem69% | $22 → $9 | Downgrade | Overweight → Neutral | Get Alert |
| 07/21/2014 | AMPH | Buy Now | Amphastar Pharma | $24.16 | -25.5% | David Amsellem69% | → $18 | Initiates | → Overweight | Get Alert |
| 07/07/2014 | HZNP | Buy Now | Horizon Therapeutics | — | — | David Amsellem69% | — | Assumes | → Overweight | Get Alert |
| 05/05/2014 | ADMS | Buy Now | Adamas Pharmaceuticals | — | — | David Amsellem69% | → $32 | Initiates | → Overweight | Get Alert |
| 03/10/2014 | EGRX | Buy Now | Eagle Pharmaceuticals | $2.30 | 856.52% | David Amsellem69% | → $22 | Initiates | → Overweight | Get Alert |
| 03/05/2014 | HZNP | Buy Now | Horizon Therapeutics | — | — | David Amsellem69% | $17 → $21 | Maintains | Overweight | Get Alert |
| 03/03/2014 | RVNC | Buy Now | Revance Therapeutics | — | — | David Amsellem69% | → $44 | Initiates | → Overweight | Get Alert |
| 12/19/2013 | NBIX | Buy Now | Neurocrine Biosciences | $90.87 | -81.29% | David Amsellem69% | → $17 | Initiates | → Overweight | Get Alert |
| 11/06/2013 | ENDP | Buy Now | Endo International | — | — | David Amsellem69% | $26 → $58 | Upgrade | Underweight → Neutral | Get Alert |
| 11/05/2013 | ENDP | Buy Now | Endo International | — | — | David Amsellem69% | $26 → $58 | Upgrade | Underweight → Neutral | Get Alert |
| 10/21/2013 | HZNP | Buy Now | Horizon Therapeutics | — | — | David Amsellem69% | $3 → $7 | Upgrade | Neutral → Overweight | Get Alert |
| 08/06/2013 | PCRX | Buy Now | Pacira BioSciences | $24.56 | 54.72% | David Amsellem69% | $35 → $38 | Downgrade | Overweight → Neutral | Get Alert |
| 05/14/2013 | SUPN | Buy Now | Supernus Pharmaceuticals | $31.67 | -58.95% | David Amsellem69% | $14 → $13 | Maintains | Overweight | Get Alert |
| 03/15/2013 | SUPN | Buy Now | Supernus Pharmaceuticals | $31.67 | -55.79% | David Amsellem69% | $15 → $14 | Maintains | Overweight | Get Alert |
| 03/11/2013 | BDSI | Buy Now | BioDelivery Sciences Intl | — | — | David Amsellem69% | $5 → $8 | Upgrade | Neutral → Overweight | Get Alert |
| 02/27/2013 | JAZZ | Buy Now | Jazz Pharmaceuticals | $99.75 | -30.83% | David Amsellem69% | $65 → $69 | Maintains | Overweight | Get Alert |
| 02/26/2013 | IPXL | Buy Now | Impax Laboratories, Inc. | — | — | David Amsellem69% | $29 → $27 | Maintains | Overweight | Get Alert |
| 02/25/2013 | ENDP | Buy Now | Endo International | — | — | David Amsellem69% | $28 → $22 | Downgrade | Neutral → Underweight | Get Alert |
| 01/28/2013 | PCRX | Buy Now | Pacira BioSciences | $24.56 | 9.93% | David Amsellem69% | $22 → $27 | Maintains | Overweight | Get Alert |
| 01/04/2013 | ENDP | Buy Now | Endo International | — | — | David Amsellem69% | $37 → $28 | Downgrade | Overweight → Neutral | Get Alert |
| 01/04/2013 | BDSI | Buy Now | BioDelivery Sciences Intl | — | — | David Amsellem69% | → $5 | Initiates | → Neutral | Get Alert |
| 10/05/2012 | ENDP | Buy Now | Endo International | — | — | David Amsellem69% | $45 → $44 | Maintains | Overweight | Get Alert |
| 08/13/2012 | SUPN | Buy Now | Supernus Pharmaceuticals | $31.67 | -52.64% | David Amsellem69% | $12 → $15 | Maintains | Overweight | Get Alert |
| 08/08/2012 | JAZZ | Buy Now | Jazz Pharmaceuticals | $99.75 | -31.83% | David Amsellem69% | $64 → $68 | Maintains | Overweight | Get Alert |
| 07/09/2012 | AKRX | Buy Now | Akorn | — | — | David Amsellem69% | $16 → $21 | Maintains | Overweight | Get Alert |
| 07/02/2012 | IPXL | Buy Now | Impax Laboratories | — | — | David Amsellem69% | $32 → $30 | Maintains | Overweight | Get Alert |
| 03/28/2012 | PCRX | Buy Now | Pacira Pharamaceuticals | $24.56 | -38.93% | David Amsellem69% | $11 → $15 | Maintains | Overweight | Get Alert |
| 02/28/2012 | JAZZ | Buy Now | Jazz Pharmaceuticals | $99.75 | -35.84% | David Amsellem69% | $61 → $64 | Maintains | Overweight | Get Alert |
